Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): An open-label, randomised, phase 2 trial

科研成果: 期刊稿件文章同行评审

729 引用 (Scopus)

指纹

探究 'Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): An open-label, randomised, phase 2 trial' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases